JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Home・Akciju saraksts・iRhythm Technologies Inc

iRhythm Technologies Inc

Slēgts

SektorsVeselības aprūpe

119.75 -7.17

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

116.76

Max

120.74

Galvenie mērījumi
By Trading Economics
Ienākumi	11M 5.6M
Pārdošana	16M 209M
Peļņas marža	2.671
Darbinieki	2,400
EBITDA	14M 16M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+38.73% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 30. jūl.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-508M 4.1B
Iepriekšējā atvēršanas cena	126.92
Iepriekšējā slēgšanas cena	119.75

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

104.78 / 137.91 Atbalsts un pretestība

iRhythm Technologies Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 1. maijs 21:36 UTC

Iegādes, apvienošanās, pārņemšana

FTC Requires 365 Retail Markets to Divest Micromarket Kiosk Business to Clear Acquisition of Cantaloupe

2026. g. 1. maijs 20:40 UTC

Iegādes, apvienošanās, pārņemšana

Meta Platforms Acquires Humanoid Robot Startup Assured Robot Intelligence

2026. g. 1. maijs 18:37 UTC

Galvenie tirgus virzītāji

Senseonic Shares Slide on Underwritten Offering Price

2026. g. 1. maijs 16:46 UTC

Galvenie tirgus virzītāji

Stellantis, Ferrari Fall on Trump Plan to Increase Tariff on European Cars, Trucks

2026. g. 2. maijs 19:57 UTC

Iegādes, apvienošanās, pārņemšana

Berkshire CEO Greg Abel Takes the Stage, Making a Case for the Post-Buffett Era -- 3rd Update

2026. g. 2. maijs 15:24 UTC

Peļņas

Berkshire CEO Greg Abel Takes the Stage, Talks Through Quarterly Results -- Update

2026. g. 2. maijs 12:46 UTC

Peļņas

Iegādes, apvienošanās, pārņemšana

Berkshire Profits More Than Double on Gains in Insurance, Railroad, Energy Businesses -- WSJ

2026. g. 2. maijs 08:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 1. maijs 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 1. maijs 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 1. maijs 20:42 UTC

Peļņas

Western Digital Beats Earnings Estimates. The Stock Is Falling Anyway. -- Barrons.com

2026. g. 1. maijs 19:33 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 1. maijs 19:33 UTC

Tirgus saruna

Change in Fed Leadership May Hamper Crypto Rebound -- Market Talk

2026. g. 1. maijs 19:18 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Rises for Second Consecutive Week Amid Middle East Standoff -- Market Talk

2026. g. 1. maijs 19:13 UTC

Tirgus saruna

Natural Gas Rises as Markets Wait for Warmer Temperatures -- Market Talk

2026. g. 1. maijs 18:36 UTC

Peļņas

3 Takeaways From Apple Earnings. The Stock Is Surging. -- Barrons.com

2026. g. 1. maijs 18:35 UTC

Peļņas

Moderna's Covid Vaccine Is Driving Growth Again. The Stock Is Down Anyway. -- Barrons.com

2026. g. 1. maijs 18:28 UTC

Peļņas

These Stocks Are Today's Movers: Apple, Sandisk, Roblox, Intel, Ferrari, Atlassian, Western Digital, Clorox, Paramount Skydance, and More -- Barrons.com

2026. g. 1. maijs 18:27 UTC

Tirgus saruna

Gold and Silver Higher for the Day, Lower For The Week -- Market Talk

2026. g. 1. maijs 18:14 UTC

Iegādes, apvienošanās, pārņemšana

Barclays Completes Acquisition of Best Egg

2026. g. 1. maijs 18:04 UTC

Peļņas

The First $6 Trillion Company May Not Be Nvidia -- Barrons.com

2026. g. 1. maijs 17:43 UTC

Tirgus saruna

Home Sales in San Francisco Jump 22.2% in March -- Market Talk

2026. g. 1. maijs 17:37 UTC

Tirgus saruna

Crypto 'Fear and Greed Index' Returns to Neutral Reading After Brief Dip -- Market Talk

2026. g. 1. maijs 17:30 UTC

Tirgus saruna

Peļņas

Apple's 2Q Print, 3Q Guide Set Up Stock to Outperform -- Market Talk

2026. g. 1. maijs 17:28 UTC

Tirgus saruna

Peļņas

Apple's Shift From Net Cash Neutral Goal Seen as Cryptic Signal -- Market Talk

2026. g. 1. maijs 17:21 UTC

Tirgus saruna

Peļņas

Apple Seen Absorbing Higher Memory Costs -- Market Talk

2026. g. 1. maijs 17:19 UTC

Tirgus saruna

Galvenie ziņu notikumi

U.S. Oil Rig Count Rises by 1 to 408 -- Market Talk

2026. g. 1. maijs 16:38 UTC

Tirgus saruna

Institutional Markets Begin to Trade on Event Contracts -- Market Talk

2026. g. 1. maijs 16:23 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Skydance Gets a Double Upgrade. It's the Warner Bros. Deal. -- Barrons.com

2026. g. 1. maijs 16:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

Salīdzinājums

Cenas izmaiņa

iRhythm Technologies Inc Prognoze

Cenas mērķis

By TipRanks

38.73% augšup

Prognoze 12 mēnešiem

Vidējais 179.18 USD 38.73%

Augstākais 255 USD

Zemākais 147 USD

Pamatojoties uz 13 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi iRhythm Technologies Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

13 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 13 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam iRhythm Technologies Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

104.78 / 137.91Atbalsts un pretestība

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.